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Background
In juvenile idiopathic arthritis (JIA) the balance between
immune activation and regulation is disturbed. Metho-
t r e x a t e( M T X )i sac o m m o n l yu s e dd r u gt oi n d u c ed i s -
ease remission in JIA patients, but the exact
mechanisms of action remains unknown.
Aim
We hypothesized that MTX induces remission by
restoring the balance between effector (Teff) and regula-
tory T cells (Tregs). Therefore we examined the effects
of MTX on Teff/Treg activation and function in JIA
patients.
Methods
Peripheral blood mononuclear cells (PBMCs) of 25 JIA
patients were isolated prior to the start of MTX (T0)
and 3 (T3) and 6 (T6) months after MTX start. Fre-
quency and phenotype of FoxP3+ Tregs were analyzed
ex vivo by flow cytometry and their suppressive function
in CFSE suppression assays. Proliferation of CD4+ and
CD8+ Teffs was determined with CFSE upon a 4-day
culture in the presence of anti-CD3. Teffs cytokine pro-
duction was measured ex vivo by flow cytometry upon
PMA/ionomycin stimulation and in culture supernatants
with luminex.
Results
MTX does not induce changes in frequency, phenotype
or suppressive capacity in Tregs at all time points. How-
ever, Teffs show significantly increased proliferation at
T6 (mean: 76.2% of CD4+ T cells, SD 18.3%) than at T3
(39.8%, 18.7%) and T0 (49.0%, 21.1%) (p<0.01).
Moreover, Teff proliferation at T6 is similar to healthy
controls. Cytokine production (IL-10, IL-13, IL-17, IFNg,
TNFa) in supernatants was also increased at T6 com-
pared to T3 and T0.
Conclusion
In contrast to our hypothesis, we observed no effects of
MTX on Treg. Surprisingly, clinical improvement in JIA
patients treated with MTX was associated with
increased proliferation and responsiveness of Teffs. This
suggests clear modulatory effects of MTX on Teffs
rather than immunosuppression.
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